This study demonstrated the correlation between the increased mRNA levels of HMGCS2 and poor clinical outcomes as well as grade malignancy in colorectal cancer (CRC) and oral squamous cell carcinoma (OSCC) tumor biopsy from affected patients. The gene discussed is HMGCS2; the disease is neoplasm.